Loading...
Voclosporin: First Approval
Voclosporin (Lupkynis(™)) is an oral calcineurin inhibitor immunosuppressant that is being developed by Aurinia Pharmaceuticals. In January 2021, based on positive results from the pivotal phases II and III trials, oral voclosporin received its first approval in the USA for use in combination with a...
Na minha lista:
| Udgivet i: | Drugs |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8010786/ https://ncbi.nlm.nih.gov/pubmed/33788181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01488-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|